Self-amplifying RNA synthesis market to reach $310.8m by 2030

Its growth is attributed to a rise in infectious diseases.

The global self-amplifying ribonucleic acid (RNA) synthesis market is projected to reach $310.8m by 2030 at a compound annual growth rate of 19.24%, according to Research and Markets.

The sector’s expansion is attributed to an upsurge in infectious diseases and the rising demand for RNA-based vaccines and therapies, and personalised medicine.

“Beyond vaccines, saRNA shows promise across cancer, genetic disorders, and autoimmune diseases,” the report said.

Meanwhile, continuous advancements in RNA technology, coupled with the increasing number of clinical trials, are expected to drive further market growth.